Immuno-Oncology Assay Industry Analysis – Opportunities, Risks & Challenges
The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28.
Market Overview:
This report presents an extensive evaluation of the Immuno-Oncology Assay Market, focusing on historical data from 2018 to 2021 while offering detailed forecasts for the period between 2023 to 2028. The analysis encompasses various aspects, including market Size, Share, Growth, Analysis, Trends and competitive insights.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Get Free Sample Copy of the Report - https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html****
Table of Contents (Immuno-Oncology Assay Market)
- Executive Summary
- Market Definition & Research Methodology
- Market Dynamics: Drivers, Challenge, Trend and Opportunities
- Segment Analysis and Geographical Breakdown
- Competitive Landscape & Strategic Initiatives
- Regulatory Environment & Policy Factors
- Growth Forecast Model (2023–2028)
- Appendix: Company Profiles, Data Sources, Methodology
What’s covered in the report?
Market Key Driver:
Increasing Cancer Cases Globally to Drive Immuno-Oncology Assay Market– The substantial growth in the Global Immuno-Oncology Assay Market has been attributed to the increasing prevalence of cancer globally. The global incidence of cancer has risen significantly, with notable increases reported in countries such as the US and India, as documented by leading healthcare organizations like the World Health Organization, the International Agency for Research on Cancer, and the Global Cancer Observatory. For instance,
- In 2018, the Global Cancer Observatory recorded approximately 18.1 million cancer cases worldwide, a number that escalated to approximately 19.2 million by 2020.
Full Report Summery [TOC + Content] - https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html
Leading players of Immuno-Oncology Assay Market including:
- Agilent Technologies Inc.
- Aviva Systems Biology Corporation
- PerkinElmer Inc.
- Bio-Rad Laboratories, Inc.
- Illumina Inc.
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- NanoString Technologies, Inc.
- BioGenex
- Abbott Laboratories, Inc.
- Asuragen Inc.
- Meso Scale Assay, LLC
- Merck Millipore
- Enzo Biochem Inc.
- Others
Immuno-Oncology Assay Market Segmentation:
By Product & Services
- Reagents and Antibodies
- Testing Kits
- Instruments
- Consumables & Accessories
- Software
Among them, reagents and antibodies are pivotal components that play a significant role in cancer diagnosis and monitoring, owing to which, they have been dominating the Global Immuno-Oncology Assay Market over the historical years.
By Assay Type
- Checkpoint Inhibitor Assays
- Cytokine Profiling Assays
- Protein Biomarker Assays
- Genomic Sequencing and Mutational Analysis
- Immune Profiling Assays
- Tumour Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million
- Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)
By Technology
- Polymerase Chain Reaction
- Immunoassay
- Next-generation Sequencing
- In-situ Hybridization
- Flow Cytometry
- Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.)
By Indication
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Ovarian Cancer
- Others (Bladder Cancer, Melanoma, etc.)
By Application
- Clinical Assay
- Research & Development
By End User
- Hospitals
- Cancer Research Centers
- Specialty Cancer Clinics
- Clinical Laboratories
- Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.)
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
North America's preeminence in the global Immuno-Oncology Assay Market is underpinned by a multifaceted landscape shaped by various factors.
Fill the Form For Customized Report Enquiry - https://www.marknteladvisors.com/query/request-customization/immuno-oncology-assay-market.html****
Key Highlights of MarkNtel Advisors' Research Methodology
- MarkNtel Advisors uses a robust methodology for accurate market analysis.
- Research objectives are clearly defined with tailored methodologies for clients.
- A representative sample is selected to ensure reliable data collection.
- Data analysis includes cleaning, statistical evaluations, and validation checks.
- Predictive modeling forecasts trends, and reports include strategic recommendations.
About MarkNtel Advisors:
We are a leading market research firm providing research, consulting, and data-driven intelligence to clients across diverse industries globally. Our reports are tailored to help businesses identify lucrative opportunities and mitigate potential risks using actionable insights.
Others Report –
https://finance.yahoo.com/news/global-clinical-workflow-management-software-084700326.html
https://ar-marketresearchblog.blogspot.com/2025/06/bubble-tea-market.html
Contact Us:
MarkNtel Advisors LLP
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
For Sales Enquiries: sales@marknteladvisors.com